Comparison of Percutaneous Ablation Technologies in the Treatment of Malignant Liver Tumors

 

 Permissions and Reprints

Abstract

Tumor ablation is a minimally invasive technique used to deliver chemical, thermal, electrical, or ultrasonic damage to a specific focal tumor in an attempt to achieve substantial tumor destruction or complete eradication. As the technology continues to advance, several image-guided tumor ablations have emerged to effectively manage primary and secondary malignancies in the liver. Percutaneous chemical ablation is one of the oldest and most established techniques for treating small hepatocellular carcinomas. However, this technique has been largely replaced by newer modalities including radiofrequency ablation, microwave ablation, laser-induced interstitial thermotherapy, cryoablation, high-intensity–focused ultrasound ablation, and irreversible electroporation. Because there exist significant differences in underlying technological bases, understanding each mechanism of action is essential for achieving desirable outcomes. In this article, the authors review the current state of each ablation method including technological and clinical considerations.

• References

• 1 Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007; 33 (5) 437-447
  CrossrefPubMedGoogle Scholar
• 2 Clark TW, Soulen MC. Chemical ablation of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13 (9, Pt 2) S245-S252
  CrossrefPubMedGoogle Scholar
• 3 Shiina S, Tagawa K, Niwa Y , et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993; 160 (5) 1023-1028
  CrossrefPubMedGoogle Scholar
• 4 Lencioni R, Bartolozzi C, Caramella D , et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995; 76 (10) 1737-1746
  CrossrefPubMedGoogle Scholar
• 5 Livraghi T, Giorgio A, Marin G , et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197 (1) 101-108
  CrossrefPubMedGoogle Scholar
• 6 Da Ines D, Buc E, Petitcolin V , et al. Massive hepatic necrosis with gastric, splenic, and pancreatic infarctions after ethanol ablation for hepatocellular carcinoma. J Vasc Interv Radiol 2010; 21 (8) 1301-1305
  CrossrefPubMedGoogle Scholar
• 7 Hasegawa S, Yamasaki N, Hiwaki T , et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999; 86 (9) 1682-1690
  CrossrefPubMedGoogle Scholar
• 8 McWilliams JP, Yamamoto S, Raman SS , et al. Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol 2010; 21 (8, Suppl): S204-S213
  CrossrefPubMedGoogle Scholar
• 9 Shiina S, Teratani T, Obi S , et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129 (1) 122-130
  CrossrefPubMedGoogle Scholar
• 10 Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127 (6) 1714-1723
  CrossrefPubMedGoogle Scholar
• 11 Lencioni RA, Allgaier HP, Cioni D , et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228 (1) 235-240
  CrossrefPubMedGoogle Scholar
• 12 Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49 (2) 453-459
  CrossrefPubMedGoogle Scholar
• 13 Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009; 104 (2) 514-524
  CrossrefPubMedGoogle Scholar
• 14 Shiina S, Tagawa K, Unuma T , et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991; 68 (7) 1524-1530
  CrossrefPubMedGoogle Scholar
• 15 Swabb EA, Wei J, Gullino PM. Diffusion and convection in normal and neoplastic tissues. Cancer Res 1974; 34 (10) 2814-2822
  PubMedGoogle Scholar
• 16 Ohnishi K, Ohyama N, Ito S, Fujiwara K. Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 1994; 193 (3) 747-752
  CrossrefPubMedGoogle Scholar
• 17 Ohnishi K, Nomura F, Ito S, Fujiwara K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology 1996; 23 (5) 994-1002
  CrossrefPubMedGoogle Scholar
• 18 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27 (1) 67-72
  CrossrefPubMedGoogle Scholar
• 19 Tamai T, Seki T, Imamura M , et al. Percutaneous injection of a low-concentration alkaline solution targeting hepatocellular carcinoma. Oncol Rep 2000; 7 (4) 719-723
  PubMedGoogle Scholar
• 20 Farnam JL, Smith BC, Johnson BR , et al. Thermochemical ablation in an ex-vivo porcine liver model using acetic acid and sodium hydroxide: proof of concept. J Vasc Interv Radiol 2010; 21 (10) 1573-1578
  CrossrefPubMedGoogle Scholar
• 21 Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6 (1) 37-48
  CrossrefPubMedGoogle Scholar
• 22 Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33 (2) 223-231
  CrossrefPubMedGoogle Scholar
• 23 Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 2005; 4 (6) 699-705
  CrossrefPubMedGoogle Scholar
• 24 Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006; 53 (7) 1409-1415
  CrossrefPubMedGoogle Scholar
• 25 Melikov KC, Frolov VA, Shcherbakov A, Samsonov AV, Chizmadzhev YA, Chernomordik LV. Voltage-induced nonconductive pre-pores and metastable single pores in unmodified planar lipid bilayer. Biophys J 2001; 80 (4) 1829-1836
  CrossrefPubMedGoogle Scholar
• 26 Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 2010; 255 (2) 426-433
  CrossrefPubMedGoogle Scholar
• 27 Thomson KR, Cheung W, Ellis SJ , et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011; 22 (5) 611-621
  CrossrefPubMedGoogle Scholar
• 28 Narayanan G, Hosein PJ, Arora G , et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 2012; 23 (12) 1613-1621
  CrossrefPubMedGoogle Scholar
• 29 Kingham TP, Karkar AM, D'Angelica MI , et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 2012; 215 (3) 379-387
  CrossrefPubMedGoogle Scholar
• 30 Silk MT, Wimmer T, Lee KS , et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol 2014; 25 (1) 112-118
  CrossrefPubMedGoogle Scholar
• 31 Cannon R, Ellis S, Hayes D, Narayanan G, Martin II RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013; 107 (5) 544-549
  CrossrefPubMedGoogle Scholar
• 32 Ng KK, Poon RT, Chan SC , et al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg 2011; 253 (5) 981-987
  CrossrefPubMedGoogle Scholar
• 33 Wu F, Wang ZB, Chen WZ , et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 2004; 11 (3-4) 149-154
  CrossrefPubMedGoogle Scholar
• 34 Lynn JG, Zwemer RL, Chick AJ, Miller AE. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942; 26 (2) 179-193
  CrossrefPubMedGoogle Scholar
• 35 Shen HP, Gong JP, Zuo GQ. Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg 2011; 77 (11) 1496-1501
  PubMedGoogle Scholar
• 36 Mearini L, Porena M. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future. Indian J Urol 2010; 26 (1) 4-11
  CrossrefPubMedGoogle Scholar
• 37 Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future?. Br J Radiol 2003; 76 (909) 590-599
  CrossrefPubMedGoogle Scholar
• 38 Zhu J, Zhu H, Mei Z , et al. High-intensity focused ultrasound ablation for treatment of hepatocellular carcinoma and hypersplenism: preliminary study. J Ultrasound Med 2013; 32 (10) 1855-1862
  CrossrefPubMedGoogle Scholar
• 39 Hesley GK, Gorny KR, Woodrum DA. MR-guided focused ultrasound for the treatment of uterine fibroids. Cardiovasc Intervent Radiol 2013; 36 (1) 5-13
  CrossrefPubMedGoogle Scholar
• 40 Mearini L. High intensity focused ultrasound, liver disease and bridging therapy. World J Gastroenterol 2013; 19 (43) 7494-7499
  CrossrefPubMedGoogle Scholar
• 41 Xu G, Luo G, He L , et al. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Ultrasound Med Biol 2011; 37 (12) 1993-1999
  CrossrefPubMedGoogle Scholar
• 42 Zhang L, Zhu H, Jin C , et al. High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 2009; 19 (2) 437-445
  CrossrefPubMedGoogle Scholar
• 43 Cheung TT, Fan ST, Chu FS , et al. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB (Oxford) 2013; 15 (8) 567-573
  CrossrefPubMedGoogle Scholar
• 44 Pacella CM, Bizzarri G, Cecconi P , et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219 (3) 669-678
  CrossrefPubMedGoogle Scholar
• 45 Wu F, Wang ZB, Chen WZ , et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005; 235 (2) 659-667
  CrossrefPubMedGoogle Scholar
• 46 Jin C, Zhu H, Wang Z , et al. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis. Eur J Radiol 2011; 80 (3) 662-669
  CrossrefPubMedGoogle Scholar
• 47 Vaezy S, Martin R, Keilman G , et al. Control of splenic bleeding by using high intensity ultrasound. J Trauma 1999; 47 (3) 521-525
  CrossrefPubMedGoogle Scholar
• 48 Noble ML, Vaezy S, Keshavarzi A , et al. Spleen hemostasis using high-intensity ultrasound: survival and healing. J Trauma 2002; 53 (6) 1115-1120
  CrossrefPubMedGoogle Scholar
• 49 Shi B, Zhu H, Liu YJ , et al. Experimental studies and clinical experiences on treatment of secondary hypersplenism with extracorporeal high-intensity focused ultrasound. Ultrasound Med Biol 2012; 38 (11) 1911-1917
  CrossrefPubMedGoogle Scholar
• 50 Pacella CM, Francica G, Di Costanzo GG. Laser ablation for small hepatocellular carcinoma. Radiol Res Pract 2011; 2011: 595627
  PubMedGoogle Scholar
• 51 Masters A, Bown SG. Interstitial laser hyperthermia in tumour therapy. Ann Chir Gynaecol 1990; 79 (4) 244-251
  PubMedGoogle Scholar
• 52 Thomsen S. Pathologic analysis of photothermal and photomechanical effects of laser-tissue interactions. Photochem Photobiol 1991; 53 (6) 825-835
  CrossrefPubMedGoogle Scholar
• 53 Jacques SL. Laser-tissue interactions. Photochemical, photothermal, and photomechanical. Surg Clin North Am 1992; 72 (3) 531-558
  PubMedGoogle Scholar
• 54 Di Costanzo GG, D'Adamo G, Tortora R , et al. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol 2013; 54 (8) 876-881
  CrossrefPubMedGoogle Scholar
• 55 Bown SG. Phototherapy in tumors. World J Surg 1983; 7 (6) 700-709
  CrossrefPubMedGoogle Scholar
• 56 Wyman DR, Whelan WM, Wilson BC. Interstitial laser photocoagulation: Nd:YAG 1064.  nm optical fiber source compared to point heat source. Lasers Surg Med 1992; 12 (6) 659-664
  CrossrefPubMedGoogle Scholar
• 57 Germer CT, Roggan A, Ritz JP , et al. Optical properties of native and coagulated human liver tissue and liver metastases in the near infrared range. Lasers Surg Med 1998; 23 (4) 194-203
  CrossrefPubMedGoogle Scholar
• 58 Ritz JP, Roggan A, Germer CT, Isbert C, Müller G, Buhr HJ. Continuous changes in the optical properties of liver tissue during laser-induced interstitial thermotherapy. Lasers Surg Med 2001; 28 (4) 307-312
  CrossrefPubMedGoogle Scholar
• 59 Tranberg KG. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol 2004; 18 (1) 125-145
  CrossrefPubMedGoogle Scholar
• 60 Pacella CM, Bizzarri G, Francica G , et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol 2005; 16 (11) 1447-1457
  CrossrefPubMedGoogle Scholar
• 61 Arienti V, Pretolani S, Pacella CM , et al. Complications of laser ablation for hepatocellular carcinoma: a multicenter study. Radiology 2008; 246 (3) 947-955
  CrossrefPubMedGoogle Scholar
• 62 Puls R, Langner S, Rosenberg C , et al. Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival. J Vasc Interv Radiol 2009; 20 (2) 225-234
  CrossrefPubMedGoogle Scholar
• 63 Orlacchio A, Bolacchi F, Chegai F , et al. Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm. Radiol Med (Torino) 2013;
  PubMedGoogle Scholar
• 64 Zou X, Liu Q, Zhou X , et al. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors. Acta Radiol 2013; 54 (2) 181-187
  CrossrefPubMedGoogle Scholar
• 65 Chen MS, Li JQ, Zheng Y , et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243 (3) 321-328
  CrossrefPubMedGoogle Scholar
• 66 McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25 (3) 267-270
  CrossrefPubMedGoogle Scholar
• 67 Buscarini E, Savoia A, Brambilla G , et al. Radiofrequency thermal ablation of liver tumors. Eur Radiol 2005; 15 (5) 884-894
  CrossrefPubMedGoogle Scholar
• 68 Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol 2009; 38 (3) 135-143
  CrossrefPubMedGoogle Scholar
• 69 Nicoli N, Casaril A, Marchiori L , et al. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chir Ital 2000; 52 (1) 29-40
  PubMedGoogle Scholar
• 70 Grasso A, Watkinson AF, Tibballs JM, Burroughs AK. Radiofrequency ablation in the treatment of hepatocellular carcinoma—a clinical viewpoint. J Hepatol 2000; 33 (4) 667-672
  CrossrefPubMedGoogle Scholar
• 71 Dong B, Liang P, Yu X , et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003; 180 (6) 1547-1555
  CrossrefPubMedGoogle Scholar
• 72 Lu MD, Xu HX, Xie XY , et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a restrospective comparative study. J Gastroenterol 2005; 40 (11) 1054-1060
  CrossrefPubMedGoogle Scholar
• 73 Shibata T, Iimuro Y, Yamamoto Y , et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223 (2) 331-337
  CrossrefPubMedGoogle Scholar
• 74 Poggi G, Montagna B, DI Cesare P , et al. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res 2013; 33 (3) 1221-1227
  PubMedGoogle Scholar
• 75 Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89 (2) 276-284
  CrossrefPubMedGoogle Scholar
• 76 Tanaka K, Shimada H, Nagano Y, Endo I, Sekido H, Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 2006; 139 (2) 263-273
  CrossrefPubMedGoogle Scholar
• 77 Cammà C, Di Marco V, Orlando A , et al; Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 2005; 42 (4) 535-540
  CrossrefPubMedGoogle Scholar
• 78 Lencioni R, Cioni D, Crocetti L , et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234 (3) 961-967
  CrossrefPubMedGoogle Scholar
• 79 Tateishi R, Shiina S, Teratani T , et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103 (6) 1201-1209
  CrossrefPubMedGoogle Scholar
• 80 Guglielmi A, Ruzzenente A, Sandri M , et al. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg 2007; 11 (2) 143-149
  CrossrefPubMedGoogle Scholar
• 81 Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 2003; 50 (50) 480-484
  PubMedGoogle Scholar
• 82 Seror O, N'Kontchou G, Ibraheem M , et al. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes—initial experience in 26 patients. Radiology 2008; 248 (1) 288-296
  CrossrefPubMedGoogle Scholar
• 83 Kuang M, Lu MD, Xie XY , et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna—experimental and clinical studies. Radiology 2007; 242 (3) 914-924
  CrossrefPubMedGoogle Scholar
• 84 Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98 (9) 1210-1224
  CrossrefPubMedGoogle Scholar
• 85 Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54 (8) 1151-1156
  CrossrefPubMedGoogle Scholar
• 86 O'Rourke AP, Haemmerich D, Prakash P, Converse MC, Mahvi DM, Webster JG. Current status of liver tumor ablation devices. Expert Rev Med Devices 2007; 4 (4) 523-537
  CrossrefPubMedGoogle Scholar
• 87 Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S187-S191
  CrossrefPubMedGoogle Scholar
• 88 Bryant G. DSC measurement of cell suspensions during successive freezing runs: implications for the mechanisms of intracellular ice formation. Cryobiology 1995; 32 (2) 114-128
  CrossrefPubMedGoogle Scholar
• 89 Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 2005; 95 (9) 1187-1191
  CrossrefPubMedGoogle Scholar
• 90 Finelli A, Rewcastle JC, Jewett MA. Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies. Curr Opin Urol 2003; 13 (3) 187-191
  CrossrefPubMedGoogle Scholar
• 91 Weber SM, Lee Jr FT, Chinn DO, Warner T, Chosy SG, Mahvi DM. Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model. Surgery 1997; 122 (4) 742-747
  CrossrefPubMedGoogle Scholar
• 92 Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002; 89 (11) 1396-1401
  CrossrefPubMedGoogle Scholar
• 93 Xu KC, Niu LZ, Zhou Q , et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol 2009; 15 (29) 3664-3669
  CrossrefPubMedGoogle Scholar
• 94 Adam R, Hagopian EJ, Linhares M , et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002; 137 (12) 1332-1339 , discussion 1340
  CrossrefPubMedGoogle Scholar
• 95 Pearson AS, Izzo F, Fleming RY , et al. Intraoperative radiofrequency ablation or cryoablation for hepatic maligancies. Am J Surg 1999; 178 (6) 592-599
  CrossrefPubMedGoogle Scholar
• 96 Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23 (2) 109-113 , discussion 113–114
  CrossrefPubMedGoogle Scholar
• 97 Sheen AJ, Siriwardena AK. The end of cryotherapy for the treatment of nonresectable hepatic tumors?. Ann Surg Oncol 2005; 12 (3) 202-204
  CrossrefPubMedGoogle Scholar